血糖改善对2型糖尿病患者肺功能测定的影响:Sweet Breath研究
这项前瞻性干预研究纳入60例FEV1≤90%预计值的2型糖尿病患者,强化降糖治疗3个月后发现,HbA1c下降≥0.5%的良好应答者FVC、FEV1和PEF均显著改善,而无应答者无变化;HbA1c绝对变化独立预测FEV1和PEF的增加。
要点
- 强化降糖3个月可使HbA1c下降≥0.5%的2型糖尿病患者FVC、FEV1和PEF显著改善。
- HbA1c绝对变化与FEV1和PEF的增加独立相关。
- 糖尿病病程而非HbA1c改善与FEF25-75%变化相关。
核心结论
- 在2型糖尿病患者中,短期血糖控制改善后,反映中心气道阻塞和爆发性肌肉力量的肺功能测定指标出现显著改善。
研究设计与样本
- 前瞻性干预研究,纳入60例FEV1≤90%预计值的2型糖尿病患者,在基线和强化降糖治疗3个月后评估肺功能测定。
- HbA1c下降≥0.5%者定义为良好应答者(n=35)。
主要发现
- 良好应答者FVC从78.5±12.6%改善至83.3±14.7%(P=0.029),FEV1从75.6±15.3%改善至80.9±15.4%(P=0.010),PEF从80.4±21.6%改善至89.2±21.0%(P=0.007)。
- 无应答者上述参数无显著变化(P=0.586、P=0.987、P=0.413)。
- 良好应答者中非阻塞性通气缺陷和FEV1异常的患者比例显著下降。
- 应答者组HbA1c绝对变化与FEV1增加(r=-0.370,P=0.029)和PEF增加(r=-0.471,P=0.004)呈负相关。
- 逐步多元回归分析显示,HbA1c绝对变化独立预测FEV1增加(R²=0.175)和PEF增加(R²=0.323)。
临床怎么用
- 对2型糖尿病合并肺功能减退患者,强化降糖使HbA1c下降≥0.5%可能有助于改善中心气道阻塞和呼气肌力量相关指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type 2 diabetes exerts a deleterious effect on lung function. However, it is unknown whether an improvement in glycemic control ameliorates pulmonary function. RESEARCH DESIGN AND METHODS: Prospective interventional study with 60 patients with type 2 diabetes and forced expiratory volume in 1 s (FEV1) ≤90% of predicted. Spirometric maneuvers were evaluated at baseline and after a 3-month period in which antidiabetic therapy was intensified. Those with an HbA1c reduction of ≥0.5% were considered to be good responders (n = 35). RESULTS: Good responders exhibited a significant improvement in spirometric values between baseline and the end of the study (forced vital capacity [FVC]: 78.5 ± 12.6% vs. 83.3 ± 14.7%, P = 0.029]; FEV1: 75.6 ± 15.3% vs. 80.9 ± 15.4%, P = 0.010; and peak expiratory flow [PEF]: 80.4 ± 21.6% vs. 89.2 ± 21.0%, P = 0.007). However, no changes were observed in the group of nonresponders when the same parameters were evaluated (P = 0.586, P = 0.987, and P = 0.413, respectively). Similarly, the initial percentage of patients with a nonobstructive ventilatory defect and with an abnormal FEV1 decreased significantly only among good responders. In addition, the absolute change in HbA1c inversely correlated to increases in FEV1 (r = -0.370, P = 0.029) and PEF (r = -0.471, P = 0.004) in the responders group. Finally, stepwise multivariate regression analysis showed that the absolute change in HbA1c independently predicted increased FEV1 (R 2 = 0.175) and PEF (R 2 = 0.323). In contrast, the known duration of type 2 diabetes, but not the amelioration of HbA1c, was related to changes in forced expiratory flow between 25% and 75% of the FVC. CONCLUSIONS: In type 2 diabetes, spirometric measurements reflecting central airway obstruction and explosive muscle strength exhibit significant amelioration after a short improvement in glycemic control.
引用
- Gutiérrez-Carrasquilla L, Sánchez E, Barbé F, et al. Effect of Glucose Improvement on Spirometric Maneuvers in Patients With Type 2 Diabetes: The Sweet Breath Study. Diabetes Care. 2019. PMID: 30705064. doi:10.2337/dc18-1948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。